Cholesterol Test Market Report 2026

The cholesterol test market size has grown strongly in recent years. It will grow from $9.94 billion in 2025 to $10.8 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, rising awareness of cholesterol monitoring, expansion of diagnostic laboratory networks, growth in preventive healthcare screening, availability of affordable test kits.

The cholesterol test market size is expected to see strong growth in the next few years. It will grow to $15.25 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to increasing demand for self-monitoring diagnostic tools, rising focus on early disease detection, expansion of remote patient testing solutions, growing integration of digital health platforms, increasing adoption of personalized healthcare diagnostics. Major trends in the forecast period include increasing adoption of home-based cholesterol testing kits, rising demand for point-of-care lipid testing devices, growing use of multi-parameter lipid panels, expansion of preventive cardiovascular screening programs, enhanced focus on rapid and accurate test results.

The increasing prevalence of cardiovascular diseases is expected to drive growth in the cholesterol test market. Cardiovascular diseases (CVDs) include disorders of the heart and blood vessels such as coronary heart disease, stroke, peripheral arterial disease, aortic disease, and other related conditions. Cholesterol testing provides patients and healthcare professionals with crucial information about the risk of developing heart disease. For example, in August 2025, the National Institutes of Health, a US-based government agency, projected that between 2025 and 2050, the prevalence of cardiovascular diseases will rise by 90%, mortality by 73%, and disability-adjusted life years (DALYs) by 55%, with deaths increasing from 20.5 million to 35.6 million. Therefore, the rising prevalence and mortality of cardiovascular diseases are expected to drive the cholesterol test market.

Key companies in the cholesterol test market are developing innovative blood testing systems to improve early detection, monitor cholesterol levels, support preventive healthcare, and enable personalized treatment strategies. Blood testing systems are comprehensive platforms for analyzing blood samples to assess various biomarkers and health conditions. For instance, in March 2024, Babson Diagnostics, Inc., an Australia-based healthcare technology startup, launched the BetterWay system, which includes the MiniDraw device for fingertip sample collection. The system warms the patient’s hand, collects a pea-sized blood sample using a lancet-equipped device, and automates sample preparation, including mixing and temperature regulation, before sending the sample to Babson’s lab for analysis. BetterWay can measure cholesterol, blood cell counts, and liver, kidney, and thyroid function from minimal blood volumes, delivering results in one to two days while enhancing patient comfort and convenience. This system bridges the gap between traditional lab-based testing and point-of-care accessibility, improving routine cholesterol monitoring.

In January 2023, SD Biosensor, Inc., a South Korea-based diagnostics reagents company, and SJL Partners, a Korea-based private equity firm, acquired Meridian Bioscience, Inc. for $1.53 billion. Through this acquisition, Meridian Bioscience aims to enhance its capacity to meet growing demand for diagnostic testing and develop new solutions leveraging SD Biosensor’s industry expertise and complementary capabilities. Meridian Bioscience Inc., a US-based life sciences company, manufactures, markets, and sells diagnostic devices, including those for cholesterol and cardiac testing.

Major companies operating in the cholesterol test market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers GmbH, Fujifilm Holdings Corporation, CVS Health Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Mindray Medical International Limited, SYNLAB International GmbH, Beckman Coulter Inc., PerkinElmer Inc., Horiba Ltd., Sigma-Aldrich Corp, Randox Laboratories Ltd., Nova Biomedical Corp, Abcam plc, Sinocare Inc., ACM Global Laboratories, Clinical Reference Laboratory Inc., Sekisui Diagnostics LLC, Everlywell Inc., SpectraCell Laboratories Inc., LetsGetChecked USA, Ulta Lab Tests LLC, Cell Biolabs Inc., BioReference Health LLC, Diazyme Laboratories Inc.

North America was the largest region in the cholesterol test market in 2025. The regions covered in the cholesterol test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cholesterol test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the cholesterol test market by increasing the cost of imported diagnostic reagents, biosensors, testing strips, and electronic components used in point-of-care devices and home testing kits. Diagnostic centers and hospitals in North America and Europe are most affected due to reliance on imported consumables, while Asia-Pacific faces cost pressure on manufacturing and export of testing products. These tariffs are raising test kit prices and affecting procurement budgets. However, they are also encouraging local reagent manufacturing, regional production of diagnostic devices, and increased investment in domestic in-vitro diagnostics capabilities.

The cholesterol test market research report is one of a series of new reports that provides cholesterol test market statistics, including cholesterol test industry global market size, regional shares, competitors with a cholesterol test market share, detailed cholesterol test market segments, market trends and opportunities, and any further data you may need to thrive in the cholesterol test industry. This cholesterol test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A cholesterol test is a blood analysis that measures the levels of cholesterol and other lipids in an individual’s blood. Cholesterol is a waxy, fat-like substance that the body requires in small amounts for normal physiological functions and overall health.

The main types of cholesterol test products include test kits, test strips, and other devices. A test kit is a tool used to monitor or detect specific chemical markers, allowing individuals to check their cholesterol levels at home without visiting a healthcare facility. Common test types include total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides or very low-density lipoprotein (VLDL) cholesterol tests. These products are distributed through over-the-counter and prescription-based channels and are used by hospitals, diagnostic centers, and other healthcare providers.

The cholesterol test market includes revenues earned by entities by providing various services such as clinical laboratory testing, online lab tests, medical advice, and diagnosis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The cholesterol test market also consists of sales of handheld point-of-care testing (POCT) devices, automated analyzers, lancets, and capillaries. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.